Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal / 대한뇌졸중학회지
Journal of Stroke
; : 281-291, 2018.
Article
em En
| WPRIM
| ID: wpr-716868
Biblioteca responsável:
WPRO
ABSTRACT
The authors review the current status of percutaneous left atrial appendage (LAA) occlusion therapy in patients with atrial fibrillation with the goal to prevent ischemic stroke and systemic embolism and to reduce oral anticoagulation associated bleeding. While we cover the historical and also surgical background, and all tested devices, the main focus rests on the single currently U.S. Food and Drug Administration (FDA) approved LAA occluder, the WATCHMAN device, and its approval process. The authors also give a critical appraisal beyond the review of mere facts, trying to put the current data into perspective.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Fibrilação Atrial
/
United States Food and Drug Administration
/
Isquemia Encefálica
/
Apêndice Atrial
/
Acidente Vascular Cerebral
/
Hemorragias Intracranianas
/
Embolia
/
Hemorragia
Limite:
Humans
Idioma:
En
Revista:
Journal of Stroke
Ano de publicação:
2018
Tipo de documento:
Article